John A Faber, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2101 W John Carpenter Fwy, Irving, TX 75063 Phone: 469-759-4308 Fax: 817-335-9100 |
Mehmooda Nasir, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 800 W Airport Fwy, 430, Irving, TX 75062 Phone: 972-554-7131 |
Mayur Makwana, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 7301 State Highway 161 Ste 170, Irving, TX 75039 Phone: 214-593-6506 |
Madeline Andrew, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 511 E John Carpenter Fwy Ste 500, Irving, TX 75062 Phone: 214-265-6565 Fax: 707-581-2020 |
Karen M Bontia, M.D. Psychiatry & Neurology - Neurology Medicare: May Accept Medicare Assignments Practice Location: 2021 N Macarthur Blvd, Ste 150, Irving, TX 75061 Phone: 972-253-4270 Fax: 972-401-0458 |
Abila Farah Awan, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 818 Sutton Ct, Irving, TX 75062 Phone: 214-604-6321 |
Fatima Saherwala, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 800 W Airport Fwy, Suite 810, Irving, TX 75062 Phone: 214-452-4858 |
News Archive
A new report by researchers at the University of Melbourne and published on the preprint server bioRxiv in September 2020 reports on the use of a two-protein two-dose vaccine regimen and its immunogenicity in two animal models.
Researchers from the Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore (GIS), and Rady Children's Institute for Genomic Medicine identified a previously unknown condition affecting children, which they discovered could be prevented by administering a drug during pregnancy.
Atrial fibrillation ablation is one of the fastest growing techniques in cardiology and due to the very high number of patients that might be candidates to this procedure, a significant number of resources will have to be devoted to it to be able to treat them in the following years.
The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer's disease, Duchenne muscular dystrophy and schizophrenia.
› Verified 9 days ago